XNYS
HUN
Market cap1.90bUSD
Jul 09, Last price
10.81USD
1D
-4.34%
1Q
-20.81%
Jan 2017
-43.34%
IPO
-55.88%
Name
Huntsman Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Huntsman Corporation operates as a global producer and marketer of specialized organic chemical compounds. Its operations are structured across four distinct business divisions: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects. The Polyurethanes division supplies a range of polyurethane-based chemicals, such as methyl diphenyl diisocyanate (MDI), polyols, thermoplastic polyurethane (TPU), propylene oxide, and methyl tertiary-butyl ether. Within Performance Products, the company produces a variety of amines and maleic anhydrides, alongside other key chemicals like ethylene oxide, propylene oxide, glycols, ethylene dichloride, caustic soda, ammonia, hydrogen, methylamines, and acrylonitrile. The Advanced Materials segment focuses on advanced polymer solutions. This includes formulations based on epoxy, acrylic, polyurethane, and acrylonitrile-butadiene, as well as high-performance thermoset resins, curing and toughening agents, carbon nanotube additives, and fundamental liquid and solid resins. Finally, the Textile Effects division delivers specialized chemicals and dyes for the textile industry. Huntsman's diverse product portfolio finds extensive application across numerous industries. These span from adhesives, aerospace components, and automotive manufacturing to various construction materials, consumer goods (both durable and non-durable), electronics, insulation, and medical devices. Additionally, their chemicals are vital in packaging, coatings, power generation, refining, synthetic fibers, and the textile and dye sectors. Established in 1970, Huntsman Corporation maintains its corporate headquarters in The Woodlands, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||